| Last Name |
First Name |
Abstract |
Presentation |
| Alwan |
Al |
Managing Emerging Contaminants: A Practical Approach |
(PDF, 23pp., 96KB) |
| Session I- Wednesday Morning - Chemistry [No abstract submitted] |
(PDF, 4pp., 26KB) |
| Armbrust |
Kevin |
Occurrence, Environmental Fate, and Exposure Assessment of Selective Serotonin Reuptake Inhibitors (SSRIs) in Aquatic Environments |
(PDF, 28pp., 721KB) |
| Armstrong |
Jeffrey |
Wastewater Treatment Plant Perspectives: Preliminary Data Suggesting Endocrine Disruptor Effects of Wastewater Discharge into the Pacific Ocean |
(PDF, 19pp., 832KB) |
| Benotti |
Mark |
Occurrence and Fate of High-Volume Pharmaceuticals in Wastewater-Impacted Environments |
(PDF, 24pp., 1.02MB) |
| Bisceglia |
Kevin |
Pharmaceuticals and Personal Care Products as Environmental Contaminants (1): Preliminary Environmental Risk Calculations and Method Development for Analysis in Environmental Media via GC/MS |
[Presentation not available] |
| Black |
Marsha |
Endocrine Effects of Selective Serotonin Reuptake Inhibitors (SSRIs) on Aquatic Organisms |
(PDF, 34pp., 1010KB) |
| Overview of a Framework for Assessing the Hazards of Human Pharmaceuticals in the Environment From a SETAC Pellston Workshop |
(PDF, 21pp., 146KB) |
| Brownawell |
Bruce |
Detection and Fate of Environmental Estrogens in Wastewater-Impacted Surface and Groundwaters |
[Presentation not available] |
| Buzby |
Mary |
Perspectives From the Pharmaceutical Industry |
(PDF, 32pp., 613KB) |
| Conerly |
Octavia |
EPA Regulatory Authority and EPA Regulatory Authority and PPCPs PPCPs [No abstract submitted] |
(PDF, 16pp., 113KB) |
| Daughton |
Christian |
Overview of Science Involved with Pharmaceuticals [No abstract submitted] |
(PDF, 59pp., 2.75MB) |
| U.S. EPA Workshop:Pharmaceuticals in the Environment [No abstract submitted] |
(PDF, 7pp., 592KB) |
| Davis |
J.C. |
Conveying Risk and Progress: Communicating With the Public About Pharmaceuticals in Drinking Water |
(PDF, 19pp., 658KB) |
| Eirkson |
Charles |
Environmental Assessment for Pharmaceuticals [No abstract submitted] |
(PDF, 32pp., 325KB) |
| Galvin |
David |
Washington State and King County’s Perspective on Pharmaceutical Stewardship |
(PDF, 20pp., 1015KB) |
| Glassmeyer |
Susan |
Identifying Chemical Compounds from Wastewater Discharges |
(PDF, 15pp., 645KB) |
| Session I- Wednesday Morning - Chemistry [No abstract submitted] |
(PDF, 2pp., 17KB) |
| Graham |
David |
Mechanisms of Tetracycline Resistance Development in the Environment as Detected by Real-Time PCR |
[Presentation not available] |
| Gressitt |
Stevan |
Maine: First U.S. Legislation for Unused Pharmaceutical Returns |
(PDF, 36pp., 1.19MB) |
| Khiari |
Djanette |
Pharmaceuticals and PCPs GWRC activities [No abstract submitted] |
(PDF, 28pp., 278KB) |
| Session I- Wednesday Morning - Biology [No abstract submitted] |
(PDF, 5pp., 27KB) |
| Kibbey |
Tohren |
Adsorption of Beta-Blocker Anti-Hypertensive Pharmaceuticals to a Range of Mineral Surfaces |
[Presentation not available] |
| Knapp |
Charles |
Fate, Attenuation, and Effects of Fluoroquinolone Antibacterials in Aquatic Systems |
[Presentation not available] |
| Kostich |
Mitchell |
An Informatic Approach to Estimating Ecological Risks Posed by Pharmaceutical Use |
(PDF, 13pp., 356KB) |
| O'Connor |
Catherine |
The Metropolitan Water
Reclamation District of Greater Chicago’s Efforts To Reduce
Pharmaceuticals That Enter the Water Reclamation Plants |
(PDF, 15pp., 440KB) |
| Page |
Angela D. |
Overview of the U.S. EPA’s ORD and STAR Program [No abstract submitted] |
(PDF, 18pp., 805KB) |
| Rubinstein |
Lynn |
Collecting Unwanted Medications for Appropriate Disposal |
(PDF, 23pp., 326KB) |
| Seeger |
Vickie |
Perspectives From the DEA on What Can and Cannot Be Done Via Drug Take-Back Programs |
(PDF, 10pp., 241KB) |
| Smith |
Bobbye |
The EPA Regional Perspective – Why Pharmaceuticals in the Environment are an Emerging Science Issue to EPA’s Regions [No abstract submitted] |
(PDF, 14pp., 217KB) |
| Session I- Wednesday Morning - Biology [No abstract submitted] |
(PDF, 3pp., 25KB) |
| Session I- Wednesday Afternoon - Barriers to Moving Forward [No abstract submitted] |
(PDF, 7pp., 34KB) |
| Smith |
Charlotte |
Environmental Stewardship of Waste Pharmaceuticals From a Hospital Perspective |
(PDF, 61pp., 1.67MB) |
| Tietge |
Joseph E. |
Overview of ORD's Aquatic
Toxicology Research on Endocrine-Active Chemicals |
[Presentation not available] |
| Weinberg |
Howard |
Occurrence and Fate of Antibiotics and Other Pharmaceutically Active Compounds During Transport to and During Drinking Water Treatment |
[Presentation not available] |
| Wen |
Chen |
Session II- Wednesday Afternoon - Policy [No abstract submitted] |
(PDF, 5pp., 29KB) |
| The Programmatic and/or Regulatory Constraints to Reducing Pharmaceuticals in the Environment [No abstract submitted] |
(PDF, 4pp., 25KB) |
| Yu |
Jim |
Pharmaceuticals and Personal Care Products as Environmental Contaminants (2): Biodegradability Studies and Occurrence in Sewage Treatment Plant Influent and Effluent |
[Presentation not available] |
